Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Post-Treatment AFP Levels Predict Liver Cancer Risk in Hepatitis C
September 2025
Discover a study showing that post-treatment AFP levels help predict hepatocellular carcinoma risk in chronic hepatitis C patients after antiviral therapy.
Read more
16 Jul 2025
Oral Contraceptives Not Linked to Liver Cancer Risk, Large UK Study Finds
Large UK studies show no increased liver cancer risk with oral contraceptives, though longer use may slightly raise risk.
14 Jul 2025
Liver Disease Risk Elevated in Type 2 Diabetes
In this study, MASLD was identified in 50% of the T2DM cohort using non-invasive methods, slightly lower than some global estimates.
12 Jul 2025
Gut Microbiome's Role in MASLD Progression Uncovered
Discover a study exploring how gut microbiome imbalances contribute to MASLD progression and offer new diagnostic and therapeutic possibilities.
10 Jul 2025
Genetic Testing Improves Diagnosis in Childhood Liver Failure
Metabolic and genetic disorders emerged as the most frequent aetiological group, reflecting broader diagnostic capabilities compared to earlier studies.
8 Jul 2025
Head-to-Head Trial Supports Cheaper Hepatitis C Drug
Beyond the head-to-head comparison, the study also explored innovative strategies to simplify or shorten treatment.
6 Jul 2025
Gut-Liver Axis Key to MASLD Treatment Success
The study offers important insights into the therapeutic potential of short-chain fatty acids supplementation in MASLD, especially in non-obese patients.
4 Jul 2025
Turmeric Compound Supplementation Reduces Liver Fat in MASLD
This 12-month study explored the impact of ethanol-extracted curcumin on liver health, inflammation, and metabolic parameters in individuals with MASLD.
2 Jul 2025
Using Biomarkers to Enhance Liver Transplant Medication Adherence
The biomarker identifies those at highest risk of non-adherence and helps determine how much support they receive during the intervention.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
35
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View